000 01973cam a2200349 a 4500
003 EG-GiCUC
005 20250223030724.0
008 121210s2012 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.19.04.Ph.D.2012.Da.C
100 0 _aDalia Hamouda Elsadek Elsaid
245 1 4 _aThe correlation between hormone receptors, HER 2 and topoisomerase II and response to neoadjuvant chemotherapy in locally advanced breast cancer /
_cDalia Hamouda Elsadek Elsaid ; Supervised Nasr M. Ali Ellahloby , Magda Mourad Elsayed , Fouad Mohamed AbouTaleb
246 1 5 _aالعلاقه بين وجود مستقبلات الهرمون و الهير٢ و التوبوايزوميراز٢ و الاستجابه للعلاج الكيماوى كعلاج أولى فى حالات سرطان الثدى المتقدم
260 _aCairo :
_bDalia Hamouda Elsadek Elsaid ,
_c2012
300 _a196 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Oncology-Medical
520 _aTopoisomerase II-Ü is a molecular target of anthracyclines; several studies have suggested that topoisomerase II-Ü expression is related to response to anthracycline treatment. The objective of this study was to evaluate correlation between overexpression of Topo II-Ü, HER2-neu, and hormone receptors and response to primary anthracyclin-based chemotherapy in locally advanced breast cancer
530 _aIssued also as CD
653 4 _aAnthracycline
653 4 _aLocally advanced breast cancer
653 4 _aTopoisomerase II-Ü
700 0 _aFouad Mohamed AbouTaleb ,
_eSupervisor
700 0 _aMagda Mourad Elsayed ,
_eSupervisor
700 0 _aNasr Mohamed Ali Ellahloby ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c40559
_d40559